tiprankstipranks
Trending News
More News >
Psychemedics (PMDI)
OTHER OTC:PMDI
US Market

Psychemedics (PMDI) Price & Analysis

Compare
119 Followers

PMDI Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

38.48%1.39%4.52%55.61%
38.48% Insiders
4.52% Other Institutional Investors
55.61% Public Companies and
Individual Investors

PMDI FAQ

What was Psychemedics’s price range in the past 12 months?
Psychemedics lowest stock price was $1.11 and its highest was $3.25 in the past 12 months.
    What is Psychemedics’s market cap?
    Psychemedics’s market cap is $14.66M.
      When is Psychemedics’s upcoming earnings report date?
      Psychemedics’s upcoming earnings report date is May 13, 2025 which is 23 days ago.
        How were Psychemedics’s earnings last quarter?
        Psychemedics released its earnings results on Mar 25, 2025. The company reported $0.031 earnings per share for the quarter, beating the consensus estimate of N/A by $0.031.
          Is Psychemedics overvalued?
          According to Wall Street analysts Psychemedics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Psychemedics pay dividends?
            Psychemedics pays a Thriceyearly dividend of $0.07 which represents an annual dividend yield of N/A. See more information on Psychemedics dividends here
              What is Psychemedics’s EPS estimate?
              Psychemedics’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Psychemedics have?
              Psychemedics has 6,109,502 shares outstanding.
                What happened to Psychemedics’s price movement after its last earnings report?
                Psychemedics reported an EPS of $0.031 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of Psychemedics?
                  Currently, no hedge funds are holding shares in PMDI

                  Company Description

                  Psychemedics

                  Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Enzo Biochem
                  Prophase Labs
                  ModivCare
                  Co-Diagnostics
                  Mangoceuticals, Inc.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis